This clinical trial is focused on patients who are taking oral anticoagulant medications and are scheduled for a planned colonoscopy, a procedure to examine the inside of the colon. The study is investigating the safety of continuing anticoagulation treatment during the removal of polyps, which are small growths in the colon. The medications being studied include Apixaban, Acenocoumarol, Dabigatran Etexilate, Warfarin, Rivaroxaban, and Edoxaban. These medications are used to prevent blood clots and are known as anticoagulants.
The purpose of the study is to evaluate whether it is safe to maintain anticoagulation treatment during the removal of polyps in the colon. Participants in the study will either continue their anticoagulation medication or have a short-term interruption of the medication during the procedure. The study will monitor for any bleeding or clotting events after the procedure to determine the safety of each approach.
This trial is designed to help understand the best way to manage anticoagulation treatment during colonoscopy procedures, ensuring patient safety while effectively preventing blood clots. The study is expected to run until May 2026, with recruitment starting in May 2024.



Spain